AVITA Medical (RCEL) Revenue Growth (1y) (2019 - 2026)
AVITA Medical (RCEL) Revenue Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 13.02% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 9.42% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 7.53% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 13.63% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 13.08% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 5.75% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 95.64% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 7.30% |
| 10 | AVITA Medical | 311.50 Mn | 300.36 Mn | 17.77 Mn | 17.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.83% |
| Dec 31, 2025 | 409.75% |
| Sep 30, 2025 | -13.55% |
| Jun 30, 2025 | 19.95% |
| Mar 31, 2025 | 65.03% |
| Dec 31, 2024 | 27.14% |
| Sep 30, 2024 | 43.25% |
| Jun 30, 2024 | 29.29% |
| Mar 31, 2024 | 5.25% |
| Dec 31, 2023 | 50.13% |
| Sep 30, 2023 | 50.08% |
| Mar 31, 2023 | 39.94% |
| Sep 30, 2022 | -65.15% |
| Mar 31, 2022 | -13.99% |
| Sep 30, 2021 | 415.59% |
| Jun 30, 2021 | 391.85% |
| Mar 31, 2021 | 126.08% |
| Dec 31, 2020 | 56.58% |
| Sep 30, 2020 | 55.69% |
| Jun 30, 2020 | 57.92% |